Volume Alert - RAD 5.56 Rite Aid Corp $RAD Hit a high today

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
Volume Alert - RAD 5.56 Rite Aid Corp $RAD Hit a high today of 5.60 Closing the day 10:30 at 5.56 +0.03 +0.54% With a day low of 5.52 and a total volume of 3,141,505.

RAD Recent Posts: http://investorshangout.com/Rite-Aid-Corp-RAD-52464/

RAD Rite Aid Corp Recent Headline News

Rite Aid Provides Free Support During Affordable Care Act Enrollment Starting Nov. 15
Business Wire - 1 hr 38 mins ago
To help customers prepare for the upcoming Affordable Care Act enrollment period, Rite Aid is once again providing convenient and comprehensive resources to assist them in choosing the best health insurance choices for themselves and their families. Beginning Nov. 15, independent, licensed insurance agents will be available through a dedicated toll free number to enroll customers and provide free consultations with customers to answer questions on the Affordable Care Act.
RAD: 5.52 (-0.01)

Rite Aid Announces Key Appointments at Health Dialog
Business Wire - 2 hrs 2 mins ago
--Rite Aid's Karen Staniforth Promoted to Chief Operating Officer of Health Dialog
RAD: 5.52 (-0.01)

Downtrend Call Working As Rite Aid Stock Falls 21.3% (RAD)
Comtex SmarTrend(R) - Wed Nov 12, 9:58AM CST
SmarTrend identified a Downtrend for Rite Aid (NYSE:RAD) on July 18th, 2014 at $7.02. In approximately 4 months, Rite Aid has returned 21.31% as of today's recent price of $5.52.
RAD: 5.52 (-0.01)

How You Can Add Retail to Your Portfolio Now - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 2:28AM CST
How You Can Add Retail to Your Portfolio Now - Industry Outlook
SPLS: 13.41 (+0.04), AMZN: 314.68 (+3.17), AAP: 146.16 (-0.11), VFC: 71.24 (-0.25), M: 60.93 (-0.64), BKS: 22.74 (-0.12), TIF: 102.53 (-0.36), RL: 172.71 (-0.22), ARO: 2.92 (+0.01), RAD: 5.52 (-0.01), ANF: 29.06 (-0.29), AEO: 13.61 (-0.19), JCP: 7.00 (-0.76), CAR: 57.80 (-0.28), JWN: 73.06 (+0.21), ODP: 6.77 (-0.07), GPS: 39.15 (-0.04), FL: 55.53 (-0.20), AAPL: 112.84 (+1.59), CHS: 15.49 (-0.17)

Buckle's Shares Fall Marginally as October Comps Slip - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 5:23PM CST
Shares of The Buckle, Inc (BKE) witnessed a marginal decline of roughly 1.2%, as October comps fell 4.4%.
ZUMZ: 35.83 (-0.06), GPS: 39.15 (-0.04), BKE: 50.69 (-0.18), RAD: 5.52 (-0.01)

Watch for Rite Aid to Potentially Pullback After Gaining 1.10% Yesterday
Comtex SmarTrend(R) - Tue Nov 11, 4:30PM CST
Rite Aid (NYSE:RAD) traded in a range yesterday that spanned from a low of $5.45 to a high of $5.56. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $5.54 on volume of 10.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
RAD: 5.52 (-0.01)

Rite Aid and Physician Direct ACO Partner to Expand Rite Aid Health Alliance Program
Business Wire - Tue Nov 11, 8:46AM CST
Rite Aid Corporation (NYSE:RAD) has announced Physician Direct ACO, based in Sylvan Lake, Mich., as the latest healthcare provider to join its Rite Aid Health Alliance initiative. Through Rite Aid Health Alliance, physicians, Rite Aid pharmacists and special care coaches provide comprehensive care and support to individuals with chronic and poly-chronic health conditions, helping them achieve health improvement goals established by their physicians.
RAD: 5.52 (-0.01)

Strong Holiday Season Likely for Retailers? - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 3:54AM CST
Strong Holiday Season Likely for Retailers? - Industry Outlook
CATO: 37.74 (+0.02), ZUMZ: 35.83 (-0.06), LB: 77.14 (-0.80), FRED: 16.72 (+0.04), GPS: 39.15 (-0.04), BKE: 50.69 (-0.18), WAG: 67.05 (-0.39), RAD: 5.52 (-0.01), SMRT: 13.36 (-0.15)

Strong Holiday Season Likely for Retailers? - Zacks Analyst Interviews
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 3:54AM CST
Strong Holiday Season Likely for Retailers? - Zacks Analyst Interviews
CATO: 37.74 (+0.02), ZUMZ: 35.83 (-0.06), LB: 77.14 (-0.80), FRED: 16.72 (+0.04), GPS: 39.15 (-0.04), BKE: 50.69 (-0.18), WAG: 67.05 (-0.39), RAD: 5.52 (-0.01), SMRT: 13.36 (-0.15)

Costco's Comparable-Store Sales for October Beat Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 5:35PM CST
Shares of Costco Wholesale Corporation (COST) witnessed a marginal growth of roughly 1%, following comparable-store sales (comps) results for the four weeks ended Nov 2, 2014, faring better than analysts' expectations.
LB: 77.14 (-0.80), COST: 137.88 (+0.98), BURL: 42.00 (-0.73), RAD: 5.52 (-0.01)

L Brands' October Comparable Sales Grow on Innovations - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 3:00PM CST
Shares of L Brands, Inc. (LB) witnessed a marginal growth of roughly 1%, following comparable-store sales (comps) results for the four weeks ended Nov 1, 2014, faring better than analysts' expectations.
ZUMZ: 35.83 (-0.06), LB: 77.14 (-0.80), HBI: 109.64 (-0.67), RAD: 5.52 (-0.01)

Jim Cramer Answers Questions on Alibaba (BABA), Rite Aid (RAD), Vipshop (VIPS) and More
at The Street - Mon Nov 10, 2:39PM CST
TheStreet's Jim Cramer answers Twitter (TWTR) questions from the floor of the New York Stock Exchange.
KMI: 38.60 (+0.07), VIPS: 24.34 (+0.46), COH: 34.89 (-0.27), RDS.A: 68.48 (-0.41), EOG: 96.01 (-1.55), KORS: 71.14 (+0.14), KATE: 29.01 (-0.17), TWTR: 41.95 (-0.59), WAG: 67.05 (-0.39), RAD: 5.52 (-0.01), BABA: 115.52 (-2.68), APC: 89.28 (-2.14)

Comparing America's 3 Largest Drug Stores Companies
Joseph Cafariello - at Seeking Alpha - Mon Nov 10, 11:55AM CST

GNC: 43.42 (-0.80), WAG: 67.05 (-0.39), RAD: 5.52 (-0.01)

Rite Aid (RAD) Stock Higher Today After HealthSpot Deal
at The Street - Mon Nov 10, 11:53AM CST
Shares of Rite Aid (RAD) are up after the retail drugstore chain announced an agreement with HealthSpot, a healthcare technology company.
RAD: 5.52 (-0.01)

Rite Aid and National Foundation for Infectious Diseases Survey Indicates Most U.S. Women Believe They Are Not Up To Date on Vaccinations
Business Wire - Mon Nov 10, 9:06AM CST
A national survey from Rite Aid (NYSE: RAD) and National Foundation for Infectious Diseases (NFID) reveals that the majority of adult women living in the United States do not believe they are up to date on vaccinations to protect against many preventable diseases.
RAD: 5.52 (-0.01)

Is CVS Health's "Tobacco-Tax" Brilliant or Stupid?
Todd Campbell, The Motley Fool - Motley Fool - Sun Nov 09, 8:44AM CST
Source: CVS Health Supporters are heralding CVS Health 's decision to create narrow pharmacy networks that penalize tobacco users as a brilliant move, but detractors think it may alienate customers. Both sides have valid arguments, but I...
ESRX: 77.62 (-0.22), CTRX: 48.12 (-0.30), MCK: 204.61 (+1.48), CVS: 89.71 (+0.42), WAG: 67.05 (-0.39), RAD: 5.52 (-0.01)

You May Pay More for Health Insurance in These States
Todd Campbell, The Motley Fool - Motley Fool - Sun Nov 09, 8:23AM CST
More than 76 million baby boomers are heading into their golden years and that's  expected to create a surge in spending on everything from prescriptions to hospice care. Facing an avalanche of spending, insurers like UnitedHealth Group and ...
UNH: 96.49 (+0.81), WLP: 127.70 (+1.06), RAD: 5.52 (-0.01)

Apple Should Keep Cruising
Orange Peel Investments - at Seeking Alpha - Sat Nov 08, 2:29PM CST

WFM: 46.56 (-0.92), CVS: 89.71 (+0.42), AAPL: 112.83 (+1.58), RAD: 5.52 (-0.01)

Rite Aid and HealthSpot Announce Plans to Pilot HealthSpot Stations
Business Wire - Fri Nov 07, 9:00AM CST
Rite Aid announced today it has entered into an agreement with HealthSpot(R), a pioneer in patient and provider driven healthcare technology, to provide convenient healthcare services via private, walk-in HealthSpot stations inside select Rite Aid locations. Rite Aid will pilot the HealthSpot stations in the greater Akron/Canton, Cleveland and Dayton/Springfield markets.
RAD: 5.52 (-0.01)

Lull At The Mall Just Retail's Calm Before Christmas?
at Investor's Business Daily - Thu Nov 06, 5:22PM CST
Shoppers spent less freely in October as they took a break heading into the holiday season's traditional buying frenzy, leading to slow mall traffic and mixed sales reports from retailers Thursday. The jury is still out on how retailers will fare...
ZUMZ: 35.83 (-0.06), M: 60.93 (-0.64), WMT: 82.03 (+2.83), KORS: 71.14 (+0.14), FIVE: 41.78 (-0.38), RAD: 5.52 (-0.01), LB: 77.16 (-0.78), JWN: 73.06 (+0.21), COST: 137.87 (+0.97), GPS: 39.15 (-0.04), KATE: 29.01 (-0.17), AAPL: 112.83 (+1.58), BKE: 50.69 (-0.18), WAG: 67.05 (-0.39), SMRT: 13.36 (-0.15)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 220

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 0

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 90

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 228

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 408

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 39

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 164

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 208

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 237

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

SoftBank Expands AI Infrastructure with DigitalBridge Deal

Updated Category News Views 109

SoftBank's Strategic Move in AI Infrastructure SoftBank Group Corp. has recently announced its plans to acquire DigitalBridge Group Inc. in a cash deal worth approximately $4 billion. This move is seen as a pivotal step in SoftBank's commitment to scaling its infrastructure capabilities for artificial intelligence globally. Details of the Acquisition Under the terms of...

Continue Reading
Nio's Bold Moves in the EV Space: What Investors Should Know

Updated Category News Views 158

Forget the Noise, Nio's Got a Game Plan Back in my day, when you heard whispers about a new product launch, it was either a cause for celebration or a catastrophe waiting to happen. Nio, the fast-rising EV player from China, is set to drop its ES9 SUV this May, and trust me, eyes are on the road. They’ve laid out the details like a clear roadmap. Mark Your Calendars Qin...

Continue Reading
Graycliff Partners Declares Landmark Structures Sale to Cerberus

Updated Category News Views 166

Graycliff Partners Announces the Sale of Landmark Structures Graycliff Partners LP has revealed its decision to sell Landmark Structures, an esteemed provider of water and industrial storage infrastructure solutions, to Cerberus Capital Management, a robust investment firm with a global reach. Landmark Structures specializes in designing, manufacturing, and installing...

Continue Reading
Wedbush Recognizes Uber Technologies as a Top Investment

Updated Category News Views 229

Wedbush Identifies Uber Technologies as a Prime Investment Opportunity In a recent analysis, Wedbush has included Uber Technologies Inc (NYSE: UBER) in its prestigious 'best ideas list.' This recognition stems from the company's attractive risk/reward dynamics, particularly as its shares are trading at a lower multiple. Valuation Insights Currently, Uber's stock is...

Continue Reading
Ververica Enhances Global Impact Through Innovative Partnerships

Updated Category News Views 161

Ververica's Global Influence in Real-Time Data Streaming Ververica, the pioneers behind Apache Flink®, recently highlighted its expanding global impact during the Flink Forward Jakarta event. This flagship occasion, known for focusing on cutting-edge data streaming technologies, served as an excellent platform for Ververica to demonstrate its dedication to helping...

Continue Reading